Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sorrento Therapeutics Inc (SRNE)

Sorrento Therapeutics Inc (SRNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,788
  • Shares Outstanding, K 551,281
  • Annual Sales, $ 62,840 K
  • Annual Income, $ -572,840 K
  • 60-Month Beta 1.93
  • Price/Sales 1.91
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade SRNE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.63
  • Most Recent Earnings $-0.17 on 08/11/23
  • Next Earnings Date 06/03/24 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 1,712.32%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0002 +4,900.00%
on 05/17/24
0.0260 -61.54%
on 05/07/24
-0.0037 (-27.01%)
since 04/26/24
3-Month
0.0001 +9,900.00%
on 04/24/24
0.0848 -88.21%
on 04/15/24
-0.0170 (-62.96%)
since 02/28/24
52-Week
0.0001 +9,900.00%
on 04/24/24
0.4190 -97.61%
on 07/20/23
-0.2780 (-96.53%)
since 05/26/23

Most Recent Stories

More News
Why Shares of Scilex Slumped This Week

A stock sale and confusion regarding its parent company are factors dragging down the stock.

SRNE : 0.0100 (-4.76%)
SRNEQ : 0.0300 (+3.45%)
SCLX : 1.0800 (-4.42%)
Why Sorrento Therapeutics Stock Crashed Today

Any euphoria after the biotech stock's big jump yesterday didn't last long.

SRNE : 0.0100 (-4.76%)
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

SRNE : 0.0100 (-4.76%)
SNY : 47.94 (-1.24%)
Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case

/PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...

SRNE : 0.0100 (-4.76%)
SCLX : 1.0800 (-4.42%)
Why Shares of Sorrento Therapeutics Are Up Today

The company is walling off subsidiary Scilex from its bankruptcy proceedings.

SRNE : 0.0100 (-4.76%)
Sorrento Therapeutics, Inc. Receives Court Approval for "First Day" Employee Wages and Cash Management Motions

/PRNewswire/ -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to...

SRNE : 0.0100 (-4.76%)
SCLX : 1.0800 (-4.42%)
Sorrento Therapeutics (SRNE) Loses -77.24% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Sorrento Therapeutics (SRNE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street...

SRNE : 0.0100 (-4.76%)
Why Sorrento Therapeutics Stock Is Crashing Today

A bankruptcy filing is weighing on the drugmaker's shares today.

SRNE : 0.0100 (-4.76%)
Wall Street Thinks These 2 Penny Stocks Could Go Parabolic

Wall Street is bullish on these two beaten-down healthcare stocks.

ATAI : 1.6600 (+3.11%)
SRNE : 0.0100 (-4.76%)
Is AMN Healthcare Services (AMN) Stock Outpacing Its Medical Peers This Year?

Here is how AMN Healthcare Services (AMN) and Sorrento Therapeutics (SRNE) have performed compared to their sector so far this year.

AMN : 55.27 (-1.72%)
SRNE : 0.0100 (-4.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and...

See More

Key Turning Points

3rd Resistance Point 0.0163
2nd Resistance Point 0.0147
1st Resistance Point 0.0123
Last Price 0.0100
1st Support Level 0.0083
2nd Support Level 0.0067
3rd Support Level 0.0043

See More

52-Week High 0.4190
Fibonacci 61.8% 0.2590
Fibonacci 50% 0.2095
Fibonacci 38.2% 0.1601
Last Price 0.0100
52-Week Low 0.0001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar